SCHEMBL21292852

SCHEMBL21292852

O=C(NN=Cc1ccc(O)cc1)c1ccc(O)cc1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
POLB P06746 2/20 0.63
RRM1 P23921 1/20 0.63
GCGR P47871 1/20 0.61
NTRK1 P04629 2/20 0.59
NPSR1 Q6W5P4 1/20 0.59
PHGDH O43175 1/20 0.57
GFER P55789 1/20 0.57
MAPT P10636 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
NPC1 O15118 1/20 0.56
PKM P14618 1/20 0.56
RAB9A P51151 1/20 0.56
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
TYR P14679 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20115428 1.00 MEN1 (0.63) MEN1KMT2APOLBRRM1GCGR
SCHEMBL20115634 0.91 NPC1 (0.61) MEN1KMT2APOLBRRM1GCGR
SCHEMBL21292818 0.91 KMT2A (0.58) MEN1KMT2APOLBRRM1GCGR
SCHEMBL21292806 0.91 KMT2A (0.58) MEN1KMT2APOLBRRM1GCGR
SCHEMBL21292804 0.91 KMT2A (0.58) MEN1KMT2APOLBRRM1GCGR
SCHEMBL21292798 0.91 NPC1 (0.61) MEN1KMT2APOLBRRM1GCGR
SCHEMBL21292816 0.91 KMT2A (0.58) MEN1KMT2APOLBRRM1GCGR
SCHEMBL20115424 0.91 MEN1 (0.75) MEN1KMT2APOLBRRM1GCGR
SCHEMBL20299057 0.91 MEN1 (0.75) MEN1KMT2APOLBRRM1GCGR
SCHEMBL14448892 0.90 NTRK1 (0.72) MEN1KMT2APOLBRRM1GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112079744-B Aromatic acylhydrazone derivatives and application thereof as NA (adenosine) inhibitor 湖南大学 2021-07-30 CN claimed
CN-112079744-A Aromatic acylhydrazone derivatives and application thereof as NA (adenosine) inhibitor 湖南大学 2020-12-15 CN claimed
CN-112079744-B Aromatic acylhydrazone derivatives and application thereof as NA (adenosine) inhibitor 湖南大学 2021-07-30 CN disclosed
CN-112079744-A Aromatic acylhydrazone derivatives and application thereof as NA (adenosine) inhibitor 湖南大学 2020-12-15 CN disclosed
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.